NANOREGMED LTD

Company Registration Number:
09096454 (England and Wales)

Unaudited micro entity accounts for the year ended 30 June 2024

Period of accounts

Start date: 01 July 2023

End date: 30 June 2024

NANOREGMED LTD

Contents of the Financial Statements

for the Period Ended 30 June 2024

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Footnotes to the Balance Sheet - 7

NANOREGMED LTD

Company Information

for the Period Ended 30 June 2024




Registered office: London Bioscience
Innovation Centre
2 Royal College Street
London
England
NW1 0NH
Company Registration Number: 09096454 (England and Wales)

NANOREGMED LTD

Profit and Loss Account

for the Period Ended 30 June 2024


2024
£

2023
£
Turnover 57,571 35,179
Other Income 7,946 3,155
Cost of Materials ( 1,171 ) ( 595 )
Staff Costs ( 15,674 ) ( 4,310 )
Depreciation and Writeoffs ( 444 ) ( 651 )
Other charges ( 54,118 ) ( 47,186 )
Tax on Profit ( 0 ) ( 0 )
Profit or (Loss) for Period ( 5,890 ) ( 14,408 )

NANOREGMED LTD

Balance sheet

As at 30 June 2024


2024
£

2023
£
Fixed Assets: 1,515 1,960
Current assets: 45,974 46,914
Creditors: amounts falling due within one year: ( 4,684 )
Net current assets (liabilities): 41,290 46,914
Total assets less current liabilities: 42,805 48,874
Accruals and deferred income: ( 179 )
Total net assets (liabilities): 42,805 48,695
Capital and reserves: 42,805 48,695

NANOREGMED LTD

Balance sheet continued

For the year ending 30 June 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 22 April 2025
And Signed On Behalf Of The Board By:

Name: Hana Salussolia
Status: Director

The notes form part of these financial statements

NANOREGMED LTD

Footnotes to the Financial Statements

for the Period Ended 30 June 2024

  • 1. Employee Information

    Average number of employees: 2

NANOREGMED LTD

Footnotes to the Financial Statements

for the Period Ended 30 June 2024

  • 2. Off balance sheet disclosure

    No